Jeffrey Patrick
Technik-/Wissenschafts-/F&E-Leiter bei NUTRIBAND INC.
Vermögen: 133 634 $ am 30.04.2024
Profil
Jeffrey Patrick currently works at Ohio State University Comprehensive Cancer Center, as Director-Drug Development Institute from 2017 and Nutriband, Inc., as Chief Scientific Officer from 2018.
Dr. Patrick also formerly worked at Gilead Sciences, Inc., as Principal, Mallinckrodt Plc, as Vice President-Professional Affairs from 2010 to 2014, Sanofi, Inc., as Principal, Actelion Pharmaceuticals US, Inc., as Principal, New Haven Pharmaceuticals, Inc., as Chief Scientific Officer from 2014 to 2017, the University of Tennessee College of Pharmacy, as Assistant Professor-Pharmacy, and Mallinckrodt Pharmaceuticals Ireland Ltd., as Global Vice President-Professional Affairs from 2010 to 2014.
Dr. Patrick received his doctorate degree from The University of Tennessee Health Science Center.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NUTRIBAND, INC.
0,47% | 26.04.2024 | 36 612 ( 0,47% ) | 133 634 $ | 30.04.2024 |
Aktive Positionen von Jeffrey Patrick
| Unternehmen | Position | Beginn |
|---|---|---|
| NUTRIBAND INC. | Technik-/Wissenschafts-/F&E-Leiter | 15.05.2018 |
Ohio State University Comprehensive Cancer Center
 Ohio State University Comprehensive Cancer Center Miscellaneous Commercial ServicesCommercial Services Ohio State University Comprehensive Cancer Center provides cancer care services. It Specializes in cancer care and treatment, cancer types, benign blood diseases, cancer clinics and centers, clinical services, nursing at OSUCCC – james, genetic counseling, find a clinical trial, find a doctor, online bill pay, OSU MyChart and referring physicians. The company was founded by Arthur G. James in 1973 and is headquartered in Columbus, OH. | Corporate Officer/Principal | 01.02.2017 |
Ehemalige bekannte Positionen von Jeffrey Patrick
| Unternehmen | Position | Ende |
|---|---|---|
New Haven Pharmaceuticals, Inc.
 New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2017 |
| MALLINCKRODT PLC | Corporate Officer/Principal | 01.08.2014 |
Mallinckrodt Pharmaceuticals Ireland Ltd.
 Mallinckrodt Pharmaceuticals Ireland Ltd. Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ireland Ltd. is an Irish specialty pharmaceutical company that has been simplifying complex medical treatments for over 150 years. The company is currently supporting investigator-initiated studies and external collaborative research studies, with a focus on providing hope for patients and families. | Corporate Officer/Principal | 01.08.2014 |
| University of Tennessee College of Pharmacy | Corporate Officer/Principal | - |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
Ausbildung von Jeffrey Patrick
| The University of Tennessee Health Science Center | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| NUTRIBAND INC. | Health Technology |
| MALLINCKRODT PLC | Health Technology |
| Private Unternehmen | 5 |
|---|---|
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | Health Technology |
Sanofi, Inc.
 Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Retail Trade |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center Miscellaneous Commercial ServicesCommercial Services Ohio State University Comprehensive Cancer Center provides cancer care services. It Specializes in cancer care and treatment, cancer types, benign blood diseases, cancer clinics and centers, clinical services, nursing at OSUCCC – james, genetic counseling, find a clinical trial, find a doctor, online bill pay, OSU MyChart and referring physicians. The company was founded by Arthur G. James in 1973 and is headquartered in Columbus, OH. | Commercial Services |
Mallinckrodt Pharmaceuticals Ireland Ltd.
Mallinckrodt Pharmaceuticals Ireland Ltd. Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ireland Ltd. is an Irish specialty pharmaceutical company that has been simplifying complex medical treatments for over 150 years. The company is currently supporting investigator-initiated studies and external collaborative research studies, with a focus on providing hope for patients and families. | Health Technology |
